SALT LAKE CITY (AP) — Because of public feedback, two additional alternatives will now be studied as possible solutions to traffic congestion in Little Cottonwood Canyon: a new cog rail line plus a longer version of a proposed gondola that would begin in the valley below the mouth of the canyon. The cog rail — a diesel-powered train with a cogwheel on the track beneath it to provide traction on steep slopes — would cost an estimated $1.05 billion. The new version of the gondola would cost $576 million. Those will join three other options previously announced for more in-depth study.
Medeski Martin and Wood recently released their fourth album (one live and three studio albums) with longtime collaborator John Scofield, titled Juice. The album is a collection of free jazz tunes, including some instrumental renditions of classic rock favorites like “Light My Fire” by The Doors, “The Times They Are A-Changin” by Bob Dylan and “Sunshine of Your Love” by Cream. The instrumentals are loose, inspired by the original tunes, but given that MSMW funky groovy twist like none other. Now, they’re bringing that Juice sound to NYC on December 11th, for one funk-fusion-filled night at Terminal 5!Scofield first partnered with MMW on the 1998 album A Go Go, a jazz-funk inspired instrumental album complete with 10 original Scofield compositions. Medeski Martin and Wood took the lead on the 2006 release, Out Louder, the first to be released under the “Medeski Scofield Martin and Wood” moniker. While A Go Go featured more structured compositions, Out Louder was an experimental attempt at spontaneous co-composition. With four virtuostic musicians, that experiment was naturally successful.While the four musicians have played together intermittently, Juice marks the absolute fusion between Scofield’s jazz-funk and MMW’s avant-garde-jazz approaches. The common ground are African and Latin influences, blended into the shuffling riffs of American rock music, and the result is wholly compelling music.Read the L4LM review of Juice here. Medeski Scofield Martin and Wood will be performing at Terminal 5 on December 11th! Tickets are on-sale now!
AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMoreFacebook announced earlier this year that it was changing how its users see content on their news feeds.Facebook is now prioritizing posts from friends and family over viral content or posts from news publishers. If you like seeing GNN posts on Facebook, we urge you to change an option in your Settings.There is a feature called, “See First”, which will boost certain posts to the top of your feed (or, in this case, show stories that wouldn’t be there at all). If you log-in and go to our GNN Facebook page, look just below the GOOD HAPPENS banner, and look for the Follow button. If you hover or tap, you will notice the option to SEE First. It will look something like the drop-down menu in the image below, depending if you have already Liked and Followed our page.Reports this week show Facebook usage dropped by “roughly 50 million hours every day” — or 5%—since those changes went into effect.Maybe Aunt Millie’s dog pictures are not as engaging as Zuckerberg thought…AddThis Sharing ButtonsShare to FacebookFacebookFacebookShare to TwitterTwitterTwitterShare to EmailEmailEmailShare to RedditRedditRedditShare to MoreAddThisMore
9. Alessia Cara We’re in for an amazing week! The Phantom of the Opera celebrates its 30th anniversary on January 26 with a slew of festivities planned for January 24 and throughout the week. January 28 marks music’s biggest night with the 60th annual Grammy Awards. But before we get ahead of ourselves, we need to reveal our Culturalist Challenge results. We asked you which 2018 Grammy nominee should bow on the Great White Way. Your number one pick has always flaunted a flair for the theatrical and will even star opposite Tony nominee Bradley Cooper in the highly anticipated remake of A Star Is Born. Check out who else made the cut below!10. Kesha 7. Seth MacFarlane 1. Lady Gaga 3. Kelly Clarkson 5. Michael Bublé 6. Ed Sheeran 4. Bruno Mars (Photos: Getty Images) 2. P!nk 8. Lorde View Comments
Nambi E. Kelley (Photo courtesy of Boneau/Bryan-Brown) View Comments A stage play about the life story and written works of the late author and poet Maya Angelou has now found its scribe. Native Son and The Chi writer Nambi E. Kelley has signed on for Phenomenal Woman: Maya Angelou. The piece is being produced with the support of Angelou’s son, Guy Johnson. The play is eyeing a Broadway bow.The show will have its world premiere in the spring of 2021 at the North Carolina Black Repertory Company before playing Hattiloo Theatre in Memphis, Tennessee and the Ensemble Theatre in Houston, Texas. It had been set to premiere during the 2020 North Carolina Black Repertory Company season but was postponed due to the coronavirus. “It is a dream come true to work directly with people who knew and loved Dr. Angelou, including her son Guy, her sister friend Ms. Lydia Stuckey and the good people at Corstoria and Branded Pictures Entertainment,” said Kelley in a statement.Phenomenal Woman: Maya Angelou, is an inspiring journey of memory, song, poetry, dance and wisdom that will bring Maya’s work into present relevance. The show is a lyrical memory-play, combining Dr. Angelou’s poetry and autobiographical writings, previously unreleased anecdotes from those who knew her well, original material and music, to explore fundamental yet timely questions about human nature, giving the gift of Dr. Angelou’s brilliance and inspiration to the next generation.Kelly was chosen by literary legend Toni Morrison to adapt her novel, Jazz, for the stage. In addition to Native Son, her plays include Xtigone and Hands Up: Seven Playwrights Seven Testaments: Dead of Night…. As an actress, she has appeared in Pipeline, Two Trains Running and more.Casting and exact dates will be announced later.
Vermont Business Magazine CE Bradley Laboratories, a Brattleboro company that manufactures coatings, will design and install a system that captures and controls solvent vapors at its plant, ensuring that workers are protected from solvent emissions and that the environment is protected from a possible release of solvent emissions. In an agreement with the US Environmental Protection Agency, CE Bradley will spend $272,711 on an environmental project that consists of designing and installing a solvent emission capture and control system in the manufacturing area of its Brattleboro facility. The company will also pay a penalty of $71,000 to settle claims by EPA that it violated federal and state hazardous waste laws.CE Bradley Laboratories, Brattleboro. VBM file photo.CE Bradley, which makes coatings for the wood, metal, graphic arts and plastic industries, also agreed to maintain its facility in compliance with federal and state hazardous waste laws, including properly managing its containers of hazardous waste and ending the practice of hanging solvent-contaminated rags to dry.“This settlement will help protect workers and neighboring communities from potential exposure to hazardous wastes,” said Curt Spalding, regional administrator of EPA’s New England office. “Due to EPA’s action, the company not only has taken steps to correct the alleged violations but also has undertaken a project to create a safer workplace.”According to a 2015 complaint against the company by EPA, C.E. Bradley faced nine claims of violations of state and federal hazardous waste regulations under the Resource Conservation and Recovery Act (RCRA).The case stems from an August 2014 inspection of the facility in which inspectors found numerous drums of hazardous waste that were alleged to have been stored for well over 90 days, rags contaminated with solvents hung to dry, hazardous wastes stored in open containers, and a cracked and deteriorated concrete containment area in the main hazardous waste storage area.Storing hazardous wastes in open containers and the open air drying of solvent-contaminated rags resulted in emissions of volatile organic compounds to the air. The illegal storage of hazardous waste for an extended period of time, and cracked and deteriorated containment could have resulted in hazardous wastes being released to the environment. More information on the Resource Conservation and Recovery Act (RCRA): https://www.epa.gov/enforcement/waste-chemical-and-cleanup-enforcement#waste(link is external)Source: BOSTON – EPA 1.19.2017
Source: Telling My StoryTelling My Story artwork created by Valley Vista patients and Dartmouth College students serve as the back to the performance being held at Valley Vista on November 2nd & 3rd. Valley Vista is a 99-bed inpatient addiction treatment program for men, women and adolescents suffering from substance use disorder often complicated by co-occurring mental health conditions. Each gender-specific program is rooted in a 12-Step abstinence-based philosophy where humility, acceptance and accountability underscore the work that is done and service provided to those seeking a life of enduring recovery. Substance use disorder does not discriminate and neither does Valley Vista; each patient is treated with respect, dignity, anonymity and validation in an intimate, safe and therapeutic environment. With two beautiful locations, in Bradford and Vergennes, Vermont, Valley Vista offers recovery from addiction in humble and tranquil settings. For more information about Valley Vista inpatient services or to begin the admission process for you, a friend, co-worker or a loved one, visit www.vvista.net(link is external) or call 802.222.5201. Valley Vista can also be found on Facebook, LinkedIn and Twitter.About Telling My StoryIn 1995, Pati Hernandez began developing the program that would become Telling My Story. It started as a project at the University Settlement on the Lower East Side of Manhattan to teach literacy to Latin American women through theater.Pati then took the program to Chiapas, Mexico, where she worked with Fortaleza de la Mujer or Strength of the Mayan Woman (FOMMA) over a five-year period, using the program to empower Mayan women.In 1999, Pati relocated to Vermont and began using the Telling My Story approach to empower populations behind visible and invisible social walls – inmates, people on parole, patients at a rehabilitation facility, and survivors of domestic violence.In 2008, Telling My Story became a nonprofit organization (a 501c3) and established a dedicated and talented Board of Directors.In the beginning, Pati worked on particular issues with specific populations, such as welfare, literacy, or incarceration. Today, the organization has grown to encompass a broader analysis that includes people behinds all sorts of social walls and the ways in which linear, authoritative power structures are reified by these walls.Over a decade of work the program has also come to believe in the centrality of voice in challenging and overcoming social stratification. Voice begins with the telling of personal life experience and builds an understanding of issues based on personal experience rather than statistics and stereotypes.Source: Telling My StoryValley Vista patients and Dartmouth College students collaborate during the summer performance of Telling My Story held at the Bradford alcohol and drug treatment center. The next performance of Telling My Story will take place November 2nd & 3rd. About Valley Vista Vermont Business Magazine Valley Vista, the 99-bed inpatient alcohol and chemical dependency treatment center in Bradford, will once again host what has now become a regular performance of “Telling My Story.” The event will take place on Thursday, November 2nd and Friday, November 3rd beginning at 7pm both nights. Telling My Story is a means by which patients at the residential drug and alcohol treatment facility use theater as a medium for self reflection and relationship building.The 10-week program is a part of the Dartmouth College English Department and Women’s Gender and Sexuality Studies curriculum where students participate alongside Valley Vista Patients. Telling My Story is a non-profit organization that breaks down visible and invisible walls such as those created by addiction as well as incarceration and poverty, all of which affect many patients at the treatment center. For reservations, which are required for the performance in Bradford, contact John Caceres at Valley Vista. It is recommended that guests arrive at 6:30, photo identification is required.Telling My Story(link is external) started in 1995 by Pati Hernandez on Manhattan’s Lower Eastside at the University Settlement. The project began as an effort to teach literacy to Latin American women through theater. In a journey that took Pati to Chiapas, Mexico and ultimately to Vermont in 1999, Pati uses the Telling My Story approach to self-empower populations such as prisoners, people on parole, patients at addiction rehabilitation facilities and survivors of domestic violence to claim their voice in a world wrought with social stigmatization.”Whether in addiction or via trauma, people can create real or self-created walls isolating themselves from the world around them,” said Dawn Taylor, Clinical Director at Valley Vista. “In recovery, we often say, ‘we’re only as sick as our secrets.’ Telling My Story is an incredibly powerful means for women in our inpatient program to undergo a transformation where they tell their story, which often has never been shared with anyone. By telling their story, our patients experience an unbelievably freeing effect. We’re so thankful to Telling My Story for bringing this powerful program to our facility. It’s one of the many unique programming initiatives we’re able to offer our patients seeking enduring recovery.”Since becoming a 501c3 non-profit entity, Telling My Story(link is external) has evolved from one working with prisoners, addicts and those impacted by poverty to encompassing a greater breadth of social issues such as domestic violence, sexual abuse and objectification, and trauma-based depression. Often times the walls that are created are real, such as those within prisons, institutions and recovery-focused treatment facilities. But quite often they are the invisible walls created by societal stratification and stigmatization. Telling My Story helps participants create a voice in challenging and breaking down these barriers. The dichotomy that often exists between the Dartmouth students and Valley Vista patients is emblematic of such stratification. When 20 ivy-league students work alongside 23 female patients, the outcome can be very eye opening for both students and patients. 15 performances have taken place at the treatment facility over the past 10 years.”Most of the students are used to being the best and brightest in their lives, attending one of the most prestigious Ivy League schools in the world,” said Pati Hernandez, Founder, Facilitator and Executive Director of Telling My Story. “In many ways, it’s a mirror of the stratification experienced by both student and patient, many of whom are less fortunate than their student counterparts. From the very first ‘Platform Preparation’ experience, the walls begin to crumble as both learn about the others reality. It’s very powerful right from the get-go.”To attend the performance of Telling My Story, please contact John Caceres at [email protected](link sends e-mail). More information about Valley Vista can be found by visiting www.vvista.net(link is external). To find out more about and to support Telling My Story, visit www.tellingmystory.org(link is external).
Fast Company:BART, the regional transportation system in the San Francisco Bay Area, has a new strategy to help cope with commute-hour congestion that’s packing train platforms and cars to the gills: BART Perks, a rewards program that uses cold hard cash to make off-peak travel more enticing. BART’s leadership is betting that this unconventional short-term solution will be a big enough patch until longer term plans come to fruition.As cities grapple with ways to better manage their transit systems, BART is using a psychology-fueled strategy to solve the age-old problem of getting people to work efficiently and on time. If the grand experiment proves successful, it sets a benchmark for other municipalities struggling to alleviate commute-hour congestion on trains. Will it work?Read the whole story: Fast Company More of our Members in the Media >
Apr 29, 2010 (CIDRAP News) – Seasonal influenza vaccination coverage for the 2009-10 season surged in children and rose moderately in healthy young adults, perhaps because of increased awareness triggered by the H1N1 flu pandemic, the Centers for Disease Control and Prevention (CDC) reported today.Using two surveys, the CDC estimated that 40% of children aged 6 months through 17 years received seasonal flu shots, a relative 67% increase from the 24% level in 2008-09. For younger adults (18 to 49) without high-risk conditions, coverage was estimated at 27.6%, up about 30% from the 20.8% coverage the year before.”These higher coverage levels for 2009-10 might reflect increased awareness of the seriousness of influenza associated with the H1N1 pandemic,” the CDC said in an article in the Apr 30 Morbidity and Mortality Weekly Report. But the article also warns that, because of survey limitations, the true coverage numbers are probably lower.As the report notes, the 2009-10 seasonal vaccination drive was unusual in that it overlapped with the pandemic H1N1 vaccination effort, with the seasonal campaign starting in August and the pandemic effort in October. The two immunization drives targeted some, but not all, of the same groups. In addition, 2009-10 marked the first full year of expansion of the seasonal vaccination target groups to include all school-aged children.For demographic groups other than children and young healthy adults, the 2009-10 seasonal coverage estimates were about the same as in 2008-09, the CDC said. Uptake in younger adults with high-risk conditions was estimated at 36.2%. Coverage was estimated at 45.0% for those between 50 and 64 years and at 68.0% for those 65 and up.Coverage for the population as a whole was estimated at 39.7%. That compares with an overall estimate of 32.6% for the 2008-09 season, which was based on survey data from 19 states, as reported in MMWR in October 2009.The coverage figures in today’s report are considerably higher than those the CDC issued a few weeks ago for H1N1 vaccine uptake. Using the same two surveys, the CDC estimated overall pandemic vaccine coverage at 24% to 27%, compared with the 39.7% overall uptake of the seasonal vaccine.The CDC estimate of H1N1 vaccine coverage in children was 36.8%, compared with 40.0% for the seasonal vaccine. Overall H1N1 coverage in adults was estimated at 20.1%, versus 39.6% for the seasonal vaccine.Higher uptake of the seasonal immunization compared with the H1N1 vaccine may reflect supply and timing factors and the fact that the seasonal vaccination effort targeted a larger share of the population. The H1N1 vaccine was in limited supply when the fall H1N1 wave peaked in late October and early November, and cases had waned significantly by the time the vaccine became more plentiful in December and January. The seasonal vaccine became available in August, and availability was generally better than for the pandemic vaccine.Seasonal vaccine uptake varied widely from state to state. For children, the figures ranged from 23.6% for Nevada to 67.2% for Hawaii, with a median of 41.2%. Adult coverage by state ranged from 32.4% in Nevada to 52.5% in Minnesota, with a median of 40.6%.The CDC found ethnic disparities in vaccine uptake similar to those seen in past years. All-ages coverage was highest in non-Hispanic whites at 42.5%, followed by Asians, 41.7%; Hispanics, 33.6%; and non-Hispanic blacks, 32.2%.The data were collected between October 2009 and January 2010 through the CDC’s Behavioral Risk Factor Surveillance System surveys and the National 2009 H1N1 Flu Survey (NHFS). A total of 262,417 people responded to the telephone surveys, in which respondents were asked if they or their children had received a seasonal flu shot or an H1N1 flu shot in the preceding year and, if so, when. Estimates from the two surveys were combined.The survey data indicated that 29.1 million children and 89.7 million adults received the vaccine, for a total of 118.8 million people. But the CDC says this is an overestimate, because only 114 million to 115 million doses of vaccine were distributed. The error is attributed to nonresponse bias and recall bias in the surveys.The survey data have other limitations, including low response rates and possible confusion of H1N1 vaccine with seasonal vaccine, the report says. “Given all of these factors combined, the net bias (estimated coverage minus actual coverage) range likely is 10%-15%,” it states.On the other hand, the demand for seasonal vaccine stayed strong even after shortages emerged in some places, which suggests that a larger share of the doses were used than in past years, the report adds.CDC. Interim results: state-specific seasonal influenza vaccination coverage—United States, August 2009–January 2010. MMWR 2010 Apr 30;59(16):477-84 [Full text]MMWR articleSee also: October 2009 MMWR report on seasonal flu vaccine coverage in 2008-09http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5839a1.htmApr 1 CIDRAP News story “CDC estimates 24% of Americans received H1N1 vaccine”